| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |